Head-To-Head Contrast: Camden National (CAC) & Its Rivals

Camden National (NASDAQ: CAC) is one of 308 public companies in the “Banks” industry, but how does it contrast to its rivals? We will compare Camden National to related businesses based on the strength of its profitability, valuation, analyst recommendations, earnings, risk, dividends and institutional ownership.

Dividends

Camden National pays an annual dividend of $1.00 per share and has a dividend yield of 2.3%. Camden National pays out 36.8% of its earnings in the form of a dividend. As a group, “Banks” companies pay a dividend yield of 1.9% and pay out 35.3% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares Camden National and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Camden National $169.25 million $40.06 million 16.04
Camden National Competitors $5.50 billion $827.87 million 391.86

Camden National’s rivals have higher revenue and earnings than Camden National. Camden National is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Camden National has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Camden National’s rivals have a beta of 0.80, suggesting that their average share price is 20% less volatile than the S&P 500.

Institutional & Insider Ownership

63.4% of Camden National shares are owned by institutional investors. Comparatively, 52.0% of shares of all “Banks” companies are owned by institutional investors. 2.3% of Camden National shares are owned by insiders. Comparatively, 10.4% of shares of all “Banks” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations for Camden National and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Camden National 0 1 0 0 2.00
Camden National Competitors 2387 8759 8724 366 2.35

Camden National presently has a consensus target price of $48.00, indicating a potential upside of 10.04%. As a group, “Banks” companies have a potential downside of 11.71%. Given Camden National’s higher possible upside, equities analysts plainly believe Camden National is more favorable than its rivals.

Profitability

This table compares Camden National and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Camden National 24.70% 10.56% 1.07%
Camden National Competitors 18.55% 8.21% 0.92%

Summary

Camden National rivals beat Camden National on 9 of the 15 factors compared.

About Camden National

Camden National Corporation is a bank holding company. The Company is a diversified financial services provider. The primary business of the Company and its subsidiary, Camden National Bank (the Bank), is to attract deposits from, and to extend loans to, consumer, institutional, municipal, non-profit and commercial customers. The Company, through the Bank, offers commercial and consumer banking products and services, and through Camden Financial Consultants and Camden National Wealth Management, divisions of the Bank, brokerage and insurance services, as well as investment management and fiduciary services. The Bank is a national banking association. The Company had 61 banking centers, 84 automated teller machines and three lending offices as of December 31, 2016. The Company operates and manages the Bank’s business within Maine’s various regions, including Mid Coast, Southern, Central, Bangor and Downeast. Healthcare Professional Funding Corporation is a subsidiary of the Bank.

Receive News & Ratings for Camden National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camden National and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit